Utah Retirement Systems’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$222K Buy
+5,700
New +$184K ﹤0.01% 997
2026
Q1
Sell
-5,700
Closed -$201K 999
2025
Q4
$201K Buy
+5,700
New +$202K ﹤0.01% 967
2025
Q1
Sell
-5,700
Closed -$229K 979
2024
Q4
$229K Hold
5,700
﹤0.01% 935
2024
Q3
$361K Hold
5,700
﹤0.01% 833
2024
Q2
$302K Buy
+5,700
New +$374K ﹤0.01% 872

Other funds holding VKTX

Utah Retirement Systems's VKTX Position: Q2 2026 in Review

Utah Retirement Systems opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 5,700 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #997 among its holdings. This is a return to the name: Utah Retirement Systems previously reported a position in VKTX as recently as Q4 2025.

Utah Retirement Systems first reported a position in VKTX in Q2 2024 and has held it in 5 quarters since. The position peaked at $361K in Q3 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Utah Retirement Systems held 5,700 shares of Viking Therapeutics worth $222K as of Q2 2026.
  • Viking Therapeutics was a new Utah Retirement Systems position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Utah Retirement Systems's portfolio in Q2 2026, its #997 holding.
  • Utah Retirement Systems first reported a position in Viking Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • Utah Retirement Systems's Viking Therapeutics position peaked at $361K in Q3 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Utah Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.